Clinical Study

Exceptional Responders Pilot Study: Molecular Profiling Of Tumors From Cancer Patients Who Are Exceptional Responders

Posted Date: May 15, 2019

  • Investigator: John Morris
  • Specialties:
  • Type of Study: Drug

This study is a first step in investigating what changes in genes might make cancer patients responded well to certain drugs. We would like to test your previously collected cancer tissue, and if available your normal tissue, to find out if your response could have been caused by a change in your ge

Criteria:

To Be Eligible For This Study, Patients Must Have Been Diagnosed With A Type Of Cancer, Have Tumor S

Keywords:

Exceptional Responde, Nci9671, Oncology, Cancer, Solid Tumor

For More Information:

Uc Cancer Institute
513-584-7698
kastla@uc.edu


  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at ResearchStudies@UCHealth.com or (513) 245-3417.